| AKI | Acute kidney injury |
| AKT | Protein kinase B |
| ALT | Alanine aminotransferase |
| ApoB | Apolipoprotein B |
| ApoC-III | Apolipoprotein C-III |
| APRI | AST to platelet ratio index |
| ARRB1 | Beta-arrestin 1 |
| AUROC | Area under the receiver operating characteristic curve |
| BCAAs | Branched-chain amino acids |
| BHB | Beta-hydroxybutyrate |
| BMI | Body mass index |
| BOLD | Blood oxygen level dependent |
| cAMP | Cyclic adenosine monophosphate |
| CKD | Chronic kidney disease |
| CREB | cAMP response element-binding protein |
| DKD | Diabetic kidney disease |
| ECM | Extracellular matrix |
| eGFR | Estimated glomerular filtration rate |
| ELF | Enhanced Liver Fibrosis |
| ERK | Extracellular signal-regulated kinase |
| ESKD | End-stage kidney disease |
| FFAR1 | Free fatty acid receptor 1 |
| FGF21 | Fibroblast growth factor 21 |
| FIB-4 | Fibrosis-4 Index |
| FTO | Fat mass and obesity-associated protein |
| GDF-15 | Growth differentiation factor-15 |
| GIP | Glucose-dependent insulinotropic polypeptide |
| GLP-1 | Glucagon-like peptide-1 |
| GLP-1RAs | Glucagon-like peptide-1 receptor agonists |
| GPCR | G protein-coupled receptor |
| GPR40 | G protein-coupled receptor 40 |
| GWAS | Genome-wide association studies |
| HbA1c | Hemoglobin A1c |
| HDL | High-density lipoprotein |
| HFpEF | Heart failure with preserved ejection fraction |
| HOMA-β | Homeostatic model assessment of β-cell function |
| HOMA2-β | Homeostatic model assessment 2 of β-cell function |
| HOMA2-IR | Homeostatic model assessment 2 of insulin resistance |
| hsCRP | High-sensitivity C-reactive protein |
| hs-TnT | High-sensitivity troponin T |
| ICAM-1 | Intercellular adhesion molecule-1 |
| IGFBP-1/2 | Insulin-like growth factor binding protein-1/2 |
| IL-6 | Interleukin-6 |
| KCNQ1 | Potassium voltage-gated channel subfamily Q member 1 |
| KIM-1 | Kidney injury molecule-1 |
| LDL | Low-density lipoprotein |
| MASH | Metabolic dysfunction-associated steatohepatitis |
| MC4R | Melanocortin 4 receptor |
| MCP-1 | Monocyte chemoattractant protein-1 |
| MRI | Magnetic resonance imaging |
| MRI-PDFF | Magnetic resonance imaging–proton density fat fraction |
| mTOR | Mechanistic target of rapamycin |
| NAFLD | Non-alcoholic fatty liver disease |
| NF-κB | Nuclear factor kappa-B |
| NGAL | Neutrophil gelatinase-associated lipocalin |
| NT-proBNP | N-terminal pro-B-type natriuretic peptide |
| PRS | Polygenic risk scores |
| RAMP3 | Receptor activity-modifying protein 3 |
| SORCS1 | Sortilin-related VPS10 domain-containing receptor 1 |
| T1DM | Type 1 diabetes mellitus |
| T2DM | Type 2 diabetes mellitus |
| TCA | Tricarboxylic acid |
| TCF7L2 | Transcription factor 7-like 2 |
| TGR5 | Takeda G protein-coupled receptor 5 |
| TNF-α | Tumor necrosis factor-alpha |
| TNFR1/2 | Tumor necrosis factor receptor 1/2 |
| UACR | Urine albumin-to-creatinine ratio |
| WFS1 | Wolframin ER transmembrane glycoprotein |
| YKL-40 | Chitinase-3-like protein-1 |